KLAC vs MRVL vs ARM
161 measures in 16 categories, one definition each, computed from filings and market data.
MRVL67.0
Marvell Technology, Inc.
Technology · Semiconductors
$227.83 −5.56%$199.5B mkt cap
Score DNA
ARM79.9
Arm Holdings plc American Depositary Shares
Technology · Semiconductors
$227.80 −6.94%$243.3B mkt cap
Score DNA
Price, rebased to 100 three years ago
KLAC MRVL ARM · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 3 | 6 | 0 |
| Last Congress purchase | 2026-09-23 | 2026-08-07 | — |
| 13F net change in holders | +413 | — | +218 |
| ETFs adding shares, 30d | 1,859 | 1,835 | 230 |
| ETFs trimming, 30d | 1,478 | 1,492 | 151 |
| Net ETF funds, 30d | +381 | +343 | +79 |
Valuation
16 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| P/E (TTM) | 44.8x
47th
|
75.6x
67th
|
233.0x
94th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | — | — |
| Price / sales | 15.9x
79th
|
21.1x
88th
|
47.2x
97th
|
| Price / book | 34.1x
100th
|
10.8x
73rd
|
28.2x
97th
|
| Price / tangible book | 92.4x
97th
|
74.8x
96th
|
56.3x
93rd
|
| Price / free cash flow | 57.4x
50th
|
115.3x
81st
|
165.1x
87th
|
| Price / operating cash flow | 52.2x
67th
|
90.7x
84th
|
116.2x
93rd
|
| Enterprise value | $217.5B
88th
|
$200.9B
87th
|
$239.9B
89th
|
| EV / sales | 16.0x
79th
|
21.3x
89th
|
46.5x
100th
|
| EV / EBITDA | 35.9x
59th
|
42.2x
64th
|
174.7x
92nd
|
| EV / EBIT | 38.4x
51st
|
57.5x
70th
|
216.3x
96th
|
| EV / free cash flow | 57.7x
52nd
|
116.1x
83rd
|
162.7x
89th
|
| Earnings yield | 2.2%
68th
|
1.3%
55th
|
0.4%
36th
|
| FCF yield | 1.7%
64th
|
0.9%
41st
|
0.6%
37th
|
| Operating cash flow yield | 1.9%
48th
|
1.1%
35th
|
0.9%
28th
|
| Graham number (per share) | $19.91
23rd
|
$36.02
56th
|
$13.21
15th
|
Profitability (TTM)
12 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| Gross margin | 61.3%
84th
|
51.4%
59th
|
95.3%
100th
|
| EBITDA margin | 44.6%
91st
|
50.3%
93rd
|
26.6%
65th
|
| Operating margin | 41.7%
95th
|
16.7%
65th
|
17.3%
68th
|
| EBIT margin | 41.7%
95th
|
37.0%
91st
|
21.5%
69th
|
| Net margin | 35.6%
95th
|
27.9%
83rd
|
20.2%
71st
|
| NOPAT margin | 35.9%
95th
|
14.4%
65th
|
14.3%
64th
|
| FCF margin | 27.7%
87th
|
18.3%
69th
|
28.6%
89th
|
| Operating cash flow margin | 30.5%
84th
|
23.3%
59th
|
40.6%
91st
|
| R&D / revenue | 11.3%
28th
|
25.8%
73rd
|
57.5%
92nd
|
| SG&A / revenue | 8.3%
20th
|
8.8%
23rd
|
21.0%
73rd
|
| Stock comp / revenue | 2.3%
33rd
|
8.8%
71st
|
22.4%
93rd
|
| Effective tax rate | 13.8%
33rd
|
13.7%
30th
|
17.4%
51st
|
Returns on capital
11 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| ROE (on average equity) | 87.5%
97th
|
16.5%
68th
|
13.4%
65th
|
| ROA | 28.4%
95th
|
11.0%
72nd
|
10.1%
71st
|
| ROIC | 64.2%
92nd
|
6.9%
48th
|
14.1%
60th
|
| ROCE | 41.5%
96th
|
14.0%
69th
|
11.1%
67th
|
| Return on tangible assets | 33.3%
95th
|
14.5%
73rd
|
10.8%
67th
|
| Cash ROIC (OCF / invested capital) | 54.5%
96th
|
11.1%
38th
|
40.1%
86th
|
| Gross profitability (GP / assets) | 46.4%
93rd
|
17.6%
37th
|
43.9%
91st
|
| ROIC, 3-yr average | 80.7%
98th
|
0.2%
25th
|
15.3%
69th
|
| ROIC, 5-yr average | 1,581.4%
100th
|
-0.8%
16th
|
— |
| ROE, 5-yr average | 119.5%
100th
|
0.6%
23rd
|
— |
| Incremental ROIC | 80.1%
80th
|
25.8%
61st
|
9.3%
44th
|
Growth
17 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| Revenue growth (TTM YoY) | 11.7%
38th
|
30.6%
70th
|
25.1%
63rd
|
| Revenue growth (QoQ) | 7.1%
21st
|
13.3%
52nd
|
-13.5%
0th
|
| Revenue CAGR, 3 yr | 9.0%
64th
|
18.9%
80th
|
— |
| Revenue CAGR, 5 yr | 14.4%
71st
|
22.3%
76th
|
— |
| Gross profit CAGR, 3 yr | 9.9%
61st
|
24.3%
84th
|
— |
| Operating income CAGR, 3 yr | 12.3%
68th
|
— | — |
| Net income growth (TTM YoY) | 18.9%
34th
|
— | 49.4%
61st
|
| Net income CAGR, 3 yr | 12.6%
67th
|
— | — |
| EPS growth (TTM YoY) | 19.6%
37th
|
— | 47.6%
61st
|
| EPS CAGR, 3 yr | -47.0%
8th
|
— | — |
| EPS CAGR, 5 yr | -22.9%
15th
|
— | — |
| FCF growth (TTM YoY) | 0.6%
35th
|
13.1%
39th
|
124.4%
87th
|
| FCF CAGR, 3 yr | 4.2%
51st
|
31.2%
83rd
|
— |
| Operating cash flow CAGR, 3 yr | 4.1%
52nd
|
26.6%
78th
|
— |
| Book value CAGR, 3 yr | -39.0%
1st
|
4.0%
37th
|
— |
| Dividend CAGR, 3 yr | -50.4%
0th
|
-1.9%
11th
|
— |
| Sustainable growth rate | 68.3%
96th
|
15.2%
62nd
|
13.4%
56th
|
Margin history & stability
7 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| Gross margin, 3-yr average | 60.9%
85th
|
46.7%
49th
|
94.4%
100th
|
| Operating margin, 3-yr average | 40.4%
97th
|
3.3%
38th
|
13.7%
61st
|
| Net margin, 3-yr average | 32.4%
94th
|
2.7%
41st
|
16.4%
72nd
|
| FCF margin, 3-yr average | 29.8%
93rd
|
22.0%
75th
|
22.1%
77th
|
| Revenue stability (0-1) | 0.92
86th
|
0.89
79th
|
0.98
97th
|
| Earnings stability (0-1) | 0.73
81st
|
0.38
54th
|
1.00
100th
|
| Margin stability (0-1) | 0.99
99th
|
0.94
57th
|
0.99
97th
|
Liquidity (latest quarter)
7 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| Cash & short-term investments | $4.9B
87th
|
$3.9B
85th
|
$3.9B
84th
|
| Net cash (− = net debt) | −$1.2B
15th
|
−$1.4B
13th
|
$3.4B
96th
|
| Working capital | $8.1B
87th
|
$5.4B
85th
|
$5.1B
83rd
|
| Current ratio | 2.88
37th
|
3.17
44th
|
5.25
72nd
|
| Quick ratio | 2.03
37th
|
2.62
51st
|
5.25
79th
|
| Cash ratio (cash + ST investments / current liabilities) | 1.14
33rd
|
1.57
48th
|
3.22
69th
|
| Defensive interval (days) | 1,109 days
69th
|
684 days
41st
|
534 days
31st
|
Leverage & solvency (latest quarter)
13 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| Total debt | $6.2B
89th
|
$5.3B
85th
|
$485.0M
56th
|
| Debt / equity | 0.97
91st
|
0.29
59th
|
0.06
39th
|
| Net debt / equity | 0.20
77th
|
0.07
72nd
|
−0.39
27th
|
| Debt / assets | 34.3%
83rd
|
19.2%
63rd
|
4.3%
40th
|
| Debt / capital | 49.2%
91st
|
22.2%
59th
|
5.3%
39th
|
| Debt / EBITDA | 1.02
44th
|
1.11
47th
|
0.35
32nd
|
| Net debt / EBITDA | 0.21
72nd
|
0.28
74th
|
−2.48
26th
|
| Interest coverage (EBIT / interest) | 19.9x
65th
|
16.2x
59th
|
— |
| Cash interest coverage | 14.6x
48th
|
10.2x
37th
|
— |
| Debt payback (years of OCF) | 1.5 yrs
55th
|
2.4 yrs
67th
|
0.2 yrs
24th
|
| Liabilities / assets | 64.6%
95th
|
32.7%
53rd
|
22.9%
37th
|
| IS credit model rating | AA | AA | AA |
| Implied credit spread (bps) | 80
19th
|
80
19th
|
80
19th
|
Efficiency
11 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| Asset turnover | 0.80
85th
|
0.39
23rd
|
0.50
41st
|
| Fixed asset turnover | 9.84
87th
|
6.94
68th
|
3.71
37th
|
| Inventory turnover | 1.5
10th
|
3.8
83rd
|
— |
| Receivables turnover | 5.3
32nd
|
5.1
29th
|
4.2
17th
|
| Days sales outstanding | 69 days
68th
|
71 days
71st
|
86 days
83rd
|
| Days inventory outstanding | 238 days
90th
|
96 days
17th
|
— |
| Days payables outstanding | 38 days
23rd
|
56 days
67th
|
94 days
89th
|
| Cash conversion cycle (days) | 270 days
93rd
|
111 days
35th
|
−7 days
1st
|
| Capex / revenue | 2.8%
28th
|
5.0%
55th
|
12.0%
81st
|
| Capex / depreciation | 0.95
54th
|
0.37
16th
|
2.35
86th
|
| Operating expense ratio | 18.9%
20th
|
36.5%
59th
|
89.6%
93rd
|
Cash flow & earnings quality
7 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| Operating cash flow / net income | 0.86
23rd
|
0.83
21st
|
2.01
67th
|
| FCF / net income | 0.78
44th
|
0.66
21st
|
1.41
79th
|
| FCF / operating cash flow | 90.9%
88th
|
78.6%
58th
|
70.4%
40th
|
| Capex / operating cash flow | 9.1%
12th
|
21.4%
42nd
|
29.6%
60th
|
| Accruals ratio | 4.0%
89th
|
1.8%
77th
|
-10.2%
15th
|
| Sloan accruals ratio | 6.3%
60th
|
8.5%
65th
|
7.1%
61st
|
| Earnings quality score (0-1) | 0.75
15th
|
0.75
15th
|
0.75
15th
|
Scores & forensic checks
15 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| IS score | 72
73rd
|
67
68th
|
80
93rd
|
| IS profitability | 98
95th
|
59
65th
|
62
68th
|
| IS growth | 71
58th
|
77
75th
|
77
74th
|
| IS value | 40
69th
|
37
53rd
|
36
44th
|
| IS momentum | 76
44th
|
87
68th
|
100
95th
|
| IS risk (safety) | 100
12th
|
100
12th
|
100
12th
|
| IS quality | 80
71st
|
73
61st
|
84
83rd
|
| IS balance sheet | 84
44th
|
85
52nd
|
93
80th
|
| IS earnings quality | 57
36th
|
61
40th
|
55
33rd
|
| IS cash flow | 67
63rd
|
58
49th
|
92
96th
|
| Piotroski F-score (0-9) | 7
65th
|
7
65th
|
7
65th
|
| Altman Z-score | 23.2
72nd
|
12.6
51st
|
91.3
97th
|
| Beneish M-score | −2.03
70th
|
−1.95
74th
|
−2.98
11th
|
| Ohlson O-score | −8.99
55th
|
−10.58
28th
|
−11.81
15th
|
| IS credit score | 87
67th
|
85
63rd
|
90
76th
|
Size (TTM)
8 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| Market cap | $216.3B
88th
|
$199.5B
87th
|
$243.3B
89th
|
| Revenue | $13.6B
85th
|
$9.5B
81st
|
$5.2B
76th
|
| EBITDA | $6.1B
88th
|
$4.8B
84th
|
$1.4B
75th
|
| Net income | $4.8B
89th
|
$2.6B
84th
|
$1.0B
81st
|
| Free cash flow | $3.8B
88th
|
$1.7B
81st
|
$1.5B
80th
|
| Total assets | $18.0B
81st
|
$27.6B
88th
|
$11.2B
75th
|
| Shareholders' equity | $6.3B
75th
|
$18.5B
89th
|
$8.6B
80th
|
| Employees | 17,100
77th
|
7,480
68th
|
9,584
72nd
|
Price performance
9 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| 1 day | −5.0% | −5.6% | −6.9% |
| 1 week | −15.2% | −17.2% | −14.4% |
| 1 month | −1.9% | −5.4% | −14.0% |
| 3 months | −20.1% | +16.9% | −15.5% |
| 6 months | −7.3% | +63.1% | +36.6% |
| Year to date | +30.5% | +155.0% | +98.5% |
| 1 year | +53.3% | +156.3% | +33.5% |
| 3 years, cumulative | +251.7% | +316.1% | +316.6% |
| 5 years, cumulative | +433.8% | +258.3% | — |
Technicals
4 measures| Measure | KLAC | MRVL | ARM |
|---|---|---|---|
| RSI 14 | 31.1 | 37.5 | 34.5 |
| From 52-week high | −46.0% | −30.9% | −49.7% |
| From 52-week low | +55.2% | +222.3% | +127.8% |
| Beta | 1.45 | 2.26 | 3.79 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17